Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shuangjin capsule
- Development stage
- Unknown
- Lead developer
- Dalian Jinkai Technology Development
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shuangjin is a traditional Chinese medicine (TCM) formulation developed and manufactured by Dalian Jinkai Technology Development Co., Ltd., primarily indicated for the treatment of herpes zoster (shingles). It is also utilized for inflammatory conditions of the respiratory tract, including acute tonsillitis and pharyngitis. The drug is a combination of extracts from *Lonicera japonica* (honeysuckle) and *Physalis alkekengi* (Chinese lantern), which are traditionally valued for their heat-clearing and detoxifying properties. Clinically, Shuangjin exhibits antiviral and anti-inflammatory activities, helping to inhibit viral replication and modulate the inflammatory response to alleviate pain and accelerate the healing of skin lesions. It is approved in China and is typically administered as an oral capsule.
- Brand names
- Shuangjin
- Other names
- Shuangjin CapsuleShuangjin JiaonangDouble Gold Capsule
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)NF-κB
Beyond the preview
Go deeper on shuangjin capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shuangjin capsule.